Dr. Muhammad O. Toor
Claim this profileMemorial Hospital of South Bend
Studies Lung Cancer
Studies Pancreatic Cancer
21 reported clinical trials
55 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Pancreatic Cancer
PD-L1 positive
BRCA1 positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Muhammad O. Toor is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
More about Muhammad O. Toor
Clinical Trial Related8 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Muhammad O. Toor has experience with
- Pembrolizumab
- Gemcitabine Hydrochloride
- Nivolumab
- Biospecimen Collection
- Atezolizumab
- Paclitaxel
Breakdown of trials Muhammad O. Toor has run
Lung Cancer
Pancreatic Cancer
Breast cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Muhammad O. Toor specialize in?
Muhammad O. Toor focuses on Lung Cancer and Pancreatic Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Muhammad O. Toor currently recruiting for clinical trials?
Yes, Muhammad O. Toor is currently recruiting for 4 clinical trials in South Bend Indiana. If you're interested in participating, you should apply.
Are there any treatments that Muhammad O. Toor has studied deeply?
Yes, Muhammad O. Toor has studied treatments such as Pembrolizumab, Gemcitabine Hydrochloride, Nivolumab.
What is the best way to schedule an appointment with Muhammad O. Toor?
Apply for one of the trials that Muhammad O. Toor is conducting.
What is the office address of Muhammad O. Toor?
The office of Muhammad O. Toor is located at: Memorial Hospital of South Bend, South Bend, Indiana 46601 United States. This is the address for their practice at the Memorial Hospital of South Bend.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.